Prenatal substance use and mental health comorbidities predict continued use.

IF 3.2 2区心理学 Q1 PSYCHOLOGY, MULTIDISCIPLINARY

Psychology of Addictive Behaviors Pub Date : 2024-07-18 DOI:10.1037/adb0001017

Eric S Kruger, Andrea Rodriguez, Lawrence Leeman, Pilar M Sanjuan

{"title":"Prenatal substance use and mental health comorbidities predict continued use.","authors":"Eric S Kruger, Andrea Rodriguez, Lawrence Leeman, Pilar M Sanjuan","doi":"10.1037/adb0001017","DOIUrl":null,"url":null,"abstract":"Objective: Prenatal substance use is common and can affect maternal and infant health. In addition, prenatal substance use is associated with mental health comorbidities (depression, anxiety, and posttraumatic stress disorder). Unremitting prenatal substance use disorders and mental health comorbidities are associated with poor health outcomes for mothers and exposed infants. The purpose of this study was to examine how any substance use, type of substance use (polysubstance use vs. single substance use), and combinations of mental health comorbidities predict continued use during pregnancy (i.e., use in the 30 days prior to delivery).Method: Health records of patients enrolled in a comprehensive prenatal program for women with substance use disorders were retrospectively analyzed (N = 281). Urine drug screen records were used to determine substance use, and diagnostic codes were used to identify mental health comorbidities.Results: Thirty-seven percent of the sample (n = 105/281) tested positive for substances at admission and 42% (n = 119/281) demonstrated continued use. 30% of the sample (n = 85/281) had depression, anxiety, and posttraumatic stress disorder, 27% (n = 76/281) had two of the three mental health comorbidities, 26% (n = 73/281) had one of the three comorbidities, and 17% (n = 47/281) did not have a mental health comorbidity. Any substance use at admission or having all three mental health conditions were associated with continued use.Conclusions: Substance use at admission and number of mental health conditions were independent predictors of continued use, although substance use was the stronger predictor. (PsycInfo Database Record (c) 2024 APA, all rights reserved).","PeriodicalId":48325,"journal":{"name":"Psychology of Addictive Behaviors","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychology of Addictive Behaviors","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1037/adb0001017","RegionNum":2,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, MULTIDISCIPLINARY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Prenatal substance use is common and can affect maternal and infant health. In addition, prenatal substance use is associated with mental health comorbidities (depression, anxiety, and posttraumatic stress disorder). Unremitting prenatal substance use disorders and mental health comorbidities are associated with poor health outcomes for mothers and exposed infants. The purpose of this study was to examine how any substance use, type of substance use (polysubstance use vs. single substance use), and combinations of mental health comorbidities predict continued use during pregnancy (i.e., use in the 30 days prior to delivery).

Method: Health records of patients enrolled in a comprehensive prenatal program for women with substance use disorders were retrospectively analyzed (N = 281). Urine drug screen records were used to determine substance use, and diagnostic codes were used to identify mental health comorbidities.

Results: Thirty-seven percent of the sample (n = 105/281) tested positive for substances at admission and 42% (n = 119/281) demonstrated continued use. 30% of the sample (n = 85/281) had depression, anxiety, and posttraumatic stress disorder, 27% (n = 76/281) had two of the three mental health comorbidities, 26% (n = 73/281) had one of the three comorbidities, and 17% (n = 47/281) did not have a mental health comorbidity. Any substance use at admission or having all three mental health conditions were associated with continued use.

Conclusions: Substance use at admission and number of mental health conditions were independent predictors of continued use, although substance use was the stronger predictor. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

查看原文本刊更多论文

产前药物使用和精神健康合并症可预测药物的持续使用。

目的：产前使用药物很常见，会影响母婴健康。此外，产前使用药物还与精神健康合并症（抑郁症、焦虑症和创伤后应激障碍）有关。产前药物使用障碍和精神健康合并症持续存在，会对母亲和婴儿的健康造成不良影响。本研究旨在探讨任何药物使用、药物使用类型（多种药物使用与单一药物使用）以及精神健康合并症组合如何预测妊娠期间的持续使用（即分娩前 30 天内的使用）：方法：对参加产前综合治疗计划的药物使用障碍妇女的健康记录进行回顾性分析（N = 281）。尿液药物筛查记录用于确定药物使用情况，诊断代码用于确定精神健康合并症：37%的样本（n = 105/281）在入院时药物检测呈阳性，42%的样本（n = 119/281）表现为持续使用药物。30%的样本（n = 85/281）患有抑郁症、焦虑症和创伤后应激障碍，27%的样本（n = 76/281）患有这三种精神健康合并症中的两种，26%的样本（n = 73/281）患有这三种合并症中的一种，17%的样本（n = 47/281）没有精神健康合并症。入院时使用任何药物或患有三种精神疾病都与持续使用药物有关：结论：入院时使用药物和患有精神疾病的人数是持续使用药物的独立预测因素，但使用药物是更强的预测因素。(PsycInfo Database Record (c) 2024 APA, 版权所有）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Psychology of Addictive Behaviors Multiple-

CiteScore

4.90

自引率

11.80%

发文量

165

期刊介绍： Psychology of Addictive Behaviors publishes peer-reviewed original articles related to the psychological aspects of addictive behaviors. The journal includes articles on the following topics: - alcohol and alcoholism - drug use and abuse - eating disorders - smoking and nicotine addiction, and other excessive behaviors (e.g., gambling) Full-length research reports, literature reviews, brief reports, and comments are published.